Verve Therapeutics

Description

Single-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.

Related

• CRISPR Therapeutics ($CRSP)CRISPR Therapeutics develops CRISPR-based gene-editing therapies across hemoglobinopathies, oncology, diabetes, and cardiovascular disease,…
• Intellia Therapeutics ($NTLA)Develops gene-editing medicines for serious diseases. Its clinical programmes use CRISPR delivered inside the body to treat inherited…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…
• Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
• Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
• HealxHealx is a Cambridge AI-powered biotech company focused on rare-disease drug discovery and development.
• BioNTechBioNTech develops investigational therapies for cancer and infectious diseases, including mRNA cancer immunotherapies, immunomodulators,…
• CasZyme, UABDevelops CRISPR-based tools and services for clients; used by partners in agriculture, diagnostics, and research to create market-ready…
• Colossal BiosciencesDevelops CRISPR-based genomics software tools and genetic engineering programs for de-extinction, including work on woolly mammoths using…
• POWERFUL MEDICAL s.r.o.Builds AI-powered ECG analysis tools for cardiovascular care, used by clinicians and health systems for instant ECG interpretation and…
• Scribe TherapeuticsEngineers CRISPR-based therapeutics by modifying natural CRISPR systems, with treatments focused on cardiometabolic disease and…